Janney Capital Management LLC Reduces Stock Position in HUTCHMED (China) Limited (NASDAQ:HCM)

Janney Capital Management LLC cut its stake in HUTCHMED (China) Limited (NASDAQ:HCM) by 5.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 15,388 shares of the company’s stock after selling 941 shares during the quarter. Janney Capital Management LLC’s holdings in HUTCHMED were worth $222,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Rhumbline Advisers grew its position in shares of HUTCHMED by 8.1% during the 2nd quarter. Rhumbline Advisers now owns 7,553 shares of the company’s stock valued at $129,000 after purchasing an additional 564 shares in the last quarter. Vanguard Personalized Indexing Management LLC boosted its stake in HUTCHMED by 9.7% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 13,216 shares of the company’s stock valued at $226,000 after buying an additional 1,168 shares during the period. Crossmark Global Holdings Inc. grew its position in HUTCHMED by 10.7% during the fourth quarter. Crossmark Global Holdings Inc. now owns 18,591 shares of the company’s stock worth $268,000 after buying an additional 1,799 shares in the last quarter. Public Employees Retirement System of Ohio bought a new position in HUTCHMED in the 3rd quarter worth about $35,000. Finally, China Universal Asset Management Co. Ltd. raised its holdings in shares of HUTCHMED by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 5,966 shares of the company’s stock valued at $117,000 after acquiring an additional 2,321 shares in the last quarter. Hedge funds and other institutional investors own 8.82% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered HUTCHMED from a “buy” rating to a “hold” rating in a report on Monday, November 18th.

HUTCHMED Trading Down 0.2 %

Shares of NASDAQ:HCM opened at $14.18 on Thursday. HUTCHMED has a one year low of $11.93 and a one year high of $21.92. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.81 and a quick ratio of 2.68. The company’s fifty day moving average price is $15.69 and its 200-day moving average price is $17.58.

About HUTCHMED

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.